DGCI

DCGI's expert panel to review Phase III data of Covaxin today

The meeting is taking before Bharat Biotech's 'pre-submission' meeting on Wednesday with the World Health Organization (WHO), for the approval for their COVID vaccine 'Covaxin'.

published on : 22nd June 2021

India's first Covid vaccine for kids gets closer to reality, may get DGCI nod soon

ZyCoV-D, has been sent by pharmaceutical firm Zydus Cadila for emergency use authorisation to the DGCI after its clinical trials ended successfully in the country.

published on : 20th June 2021

Vaccines approved! SII, Bharat Biotech get DCGI nod for restricted use in emergency situation

SII Pune has submitted safety immunogenicity and efficacy data generated on 23,745 participants, The overall vaccine efficacy was found to be 70.42 per cent.

published on : 3rd January 2021